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Altered progesterone responsiveness leads to fe-
male infertility and cancer, but underlying mecha-
nisms remain unclear. Mice with uterine-specific
ablation of GATA binding protein 2 (Gata2) are infer-
tile, showing failures in embryo implantation, endo-
metrial decidualization, and uninhibited estrogen
signaling. Gata2 deficiency results in reduced pro-
gesterone receptor (PGR) expression and attenuated
progesterone signaling, as evidenced by genome-
wide expression profiling and chromatin immunopre-
cipitation. GATA2 not only occupies at and promotes
expression of the Pgr gene but also regulates down-
stream progesterone responsive genes in conjunc-
tion with the PGR. Additionally, Gata2 knockout
uteri exhibit abnormal luminal epithelia with ectopic
TRP63 expressing squamous cells and a cancer-
related molecular profile in a progesterone-indepen-
dent manner. Lastly, we found a conserved GATA2-
PGR regulatory network in both human and mice
based on gene signature and path analyses using
gene expression profiles of human endometrial tis-
sues. In conclusion, uterine Gata2 regulates a key
regulatory network of gene expression for progester-
one signaling at the early pregnancy stage.INTRODUCTION
Central to women’s health is the regulation of uterine function by
the ovarian steroid hormones, estradiol (E2) and progesterone1414 Cell Reports 17, 1414–1425, October 25, 2016
This is an open access article under the CC BY-NC-ND license (http://(P4), acting through their receptors, the estrogen receptor
(ESR1), and progesterone receptor (PGR). PGR is critical for
uterine function as shown in the uteri of Pgr-null (PRKO) female
mice that are unable to support embryo implantation, undergo
decidualization, or inhibit E2-induced endometrial epithelial pro-
liferation with P4 (Lydon et al., 1995). Identifying modifier genes
of PGR action and elucidating their interaction will facilitate a
comprehensive understanding of mechanisms of P4 actions.
We have identified the transcription factor GATA binding
protein 2 (Gata2) as a potential modifier of uterine P4 signaling
(Rubel et al., 2012a). Genetic ablation of Gata2 regulates many
biological processes, such as hematopoietic cell development
(Tsai et al., 1994), vascular integrity (Johnson et al., 2012), adipo-
cyte differentiation (Tong et al., 2000), and pituitary function
(Charles et al., 2006). Gata2 is expressed in the epithelium and
stroma of the uterus and the epithelial expression coincides
with that of Pgr (Rubel et al., 2012a). Gata2 has been previously
described as coordinating the transcriptional activity of other nu-
clear receptors including PGR (Bo¨hm et al., 2009; Magklara and
Smith, 2009; Nagayama et al., 2008). These findings suggest
GATA2 maybe a modifier of P4 signaling in the uterus through
interaction with PGR on the chromatin of P4 target genes.
We addressed the role of Gata2 by using the PgrCre mouse
model to ablate Gata2 in cells expressing Pgr in all compart-
ments of the uterus (Soyal et al., 2005). Mice withGata2 ablation
in the uterus were infertile, lacking both the ability to allow em-
bryo implantation and subsequent uterine stromal decidualiza-
tion. Importantly, the expression of P4 target genes and Pgr itself
were deregulated. Combining cistromic analysis with transcrip-
tomic analysis, we showed that most P4-regulated genes
contained both PGR and GATA2 chromatin occupancy demon-
strating a cooperative relationship between the two factors in
controlling P4-mediated transcription in the mouse uterus.
Gata2-ablated uteri showed alterations in epithelial morphologycreativecommons.org/licenses/by-nc-nd/4.0/).
resulting in a transition from a simple epithelium to a stratified
squamous epithelium with increased TRP63 expression. Lastly,
we present evidence that supports a conservation of theGATA2-
PGR regulatory network in human uteri.
RESULTS
In Vivo Regulation of PGR Levels and Fertility by GATA2
We first examined the correlation between GATA2 and PGR
in the human endometrium. GATA2 and PGR mRNA levels
are positively correlated in human endometrial tissues from
three independent cohorts, NCBI: GSE4888, GSE58144, and
GSE51981 (Figures 1A and 1B), supporting a conservation of
the expression between mouse and human. Given this inference
and the role of GATA2 in transcription regulation, we hypothe-
sized that GATA2may regulate P4 signaling through modulating
PGR in uterus.
To test this hypothesis, we crossed mice with a floxed
Gata2 allele (Gata2f/f) with the Pgrcre mouse to ablate Gata2 in
PGR-positive cell lineages (Pgrcre; Gata2f/f, Gata2d/d) (Charles
et al., 2006; Soyal et al., 2005). Gata2 deletion was confirmed by
qRT-PCR (Figure 1C). Expression of other Gata genes did not
showacompensatory increase inexpression inGata2d/d uteri (Fig-
ure 1C). In fact, Gata2 is the most abundant Gata factor in uterus
with its mRNA levels at least 200-foldmore than the second-high-
est expressing Gata factor, Gata6 (Figure 1C). The fertility of
Gata2d/d mice was determined after a 6-month long breeding
trial. Six Gata2f/f females delivered a total of 251 pups in 33 litters
while all six Gata2d/d mice failed to generate any offspring,
demonstrating that theGata2d/d mice were infertile. To determine
the cause of the infertility, Gata2d/d and Gata2f/f mice were
analyzed on day 5.5 of pregnancy to assess if normal embryo
implantation occurred. TheGata2d/d mice showed no embryo im-
plantation sites compared to that of Gata2f/f that averaged seven
to eight sites per mouse (Figures 1D and 1E; Table 1), demon-
strating that loss of Gata2 function leads to failure of embryo
implantation.
The PgrCre mouse also ablates genes in the granulosa cells of
the preovulatory ovarian follicle and gonadotropes of the pitui-
tary. To rule out an ovarian and/or pituitary cause of infertility,
bothGata2f/f andGata2d/dmice were subject to a superovulatory
regimen of gonadotropins, and the results showed that Gata2d/d
mice ovulated a similar numbers of eggs as controlGata2f/f mice
(27 ± 3.0 versus 23.33 ± 4.37, respectively). Furthermore, serum
P4 levels at Day 5.5 of pregnancy were similar in both the
Gata2d/d mice and Gata2f/f mice (Table 1). Thus, the ability to
ovulate and the normal serum P4 levels in combination with
the fact that pituitary-specific Gata2 knockout models are fertile
(Charles et al., 2006) confirmed that the Gata2d/d infertility
phenotype is not due to impairment of the hypothalamus-pitui-
tary-ovarian axis but intrinsic to the uterus.
To demonstrate that the infertile phenotype of the Gata2d/d
mice was of uterine origin, we assayed the ability of the uterus
to undergo a decidual reaction in response to a regimen of E2
and P4. Although Gata2f/f mice showed typical increase in uter-
ine weight, changes in uterine stromal cell shape and alkaline
phosphatase staining in the stimulated horn compared to the
unstimulated horn (Figures 1F and 1G), Gata2d/d mice failed torespond and showed no increase in uterine size, weight, stroma
cell morphology, and alkaline phosphatase activities (Figures
1H, 1I, S1A, and S1B). In addition to these changes, the mRNA
of genes known to be critical for decidualization, bone morpho-
genetic protein 2 (Bmp2), wingless-type MMTV integration site
family, member 4 (Wnt4), follistatin (Fst), FK506 binding protein
4 (Fkbp4), FK506 binding protein 5 (Fkbp5), and prostaglandin-
endoperoxide synthase 2 (Ptgs2) were significantly attenuated
in the stimulated horn of Gata2d/d mice compared to the stimu-
lated horn of Gata2f/f (Figure S1C). These findings collectively
indicate an impaired decidualization phenotype because of
Gata2 deficiency.
Because the Gata2d/d phenocopied the Pgr-null mice (Lydon
et al., 1995), we investigated if PGR expression was affected
by Gata2 deficiency. In order to control for variations of PGR
levels caused by endogenous hormones, we performed
PGR western blot analysis and immunostaining on uteri of ovari-
ectomized (OVX) mice. Gata2 deficiency led to a significant
decreased expression of both PGR-A and PGR-B isoforms (Fig-
ure 1N) that could be seen in a reduction of PGR protein in the
luminal and glandular epithelia at both baseline and in response
to P4 stimulation (Figures 1J–1M). These results collectively indi-
cate that Gata2 is required for PGR expression.
Deregulated P4 Signaling in the Pre-implantation
Gata2d/d Uterus
To determine whether the reduced PGR expression in Gata2d/d
mice impaired P4 signaling, we assayed the expression of
PGR target genes in OVX Gata2d/d and Gata2f/f uterus 6 hr
followingP4 (1mg, subcutaneously [s.c.]) or vehicle (oil) treatment.
Gata2f/f mice showed an increase in the expression of the PGR-
regulated genes amphiregulin (Areg), cytochrome P450, family
26, subfamily A, polypeptide 1 (Cyp26a1), and Indian Hedgehog
(Ihh) (Figures 2A–2C). In contrast, Gata2d/d mice showed a com-
plete loss of P4-dependent induction of Areg and Cyp26a1 (Fig-
ures2Aand2B) aswell as reduced Ihhexpressionatbothbaseline
and in response to P4 (Figure 2C). These results indicate that the
P4 signaling is attenuated on PGR-dependent marker genes in
Gata2d/d mice.
The global impact of Gata2 deficiency on P4 signaling was
assayed by conducting microarray analysis on the uteri of
OVX Gata2f/f and Gata2d/d mice with P4 treatment. Comparison
between P4- versus vehicle-treated groups identified 1,861 P4
response genes (Figure 2D, green box; Table S1) in Gata2f/f
mice, whereas only 139 genes responded to P4 stimulation in
Gata2d/d mice (Figure 2D, red box; Table S2). Strikingly, P4
failed to regulate 1,814 (97%) of P4 response genes in
Gata2d/d mice (Figure 2D, Venn diagram). Moreover, of the 47
P4 response genes that remained responsive to P4 stimulation
in the Gata2d/d background, many genes exhibit diminished
magnitude on change of gene expression in response to P4
(Figure 2E). We also identified 2,461 probes that represent
the Gata2-dependent transcription profile in the uterus by
comparing expression arrays of Gata2f/f and Gata2d/d mice
under P4 treatment (Figure 2F; Table S3). Based on this profile,
the Ingenuity Pathway Analysis (IPA) predicted inhibition of P4
signaling (activation Z score 4.05) and activation of P4 antag-
onist mifepristone (activation Z score 2.09) (Figure 2G). TheseCell Reports 17, 1414–1425, October 25, 2016 1415
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Figure 1. Regulation of PGR Expression by GATA2
(A and B) Correlation between GATA2 and PGR mRNA levels in human tissues. N, number of samples; r, Pearson’s correlation coefficient.
(C) mRNA levels of Gata factors in wild-type and Gata2dd mouse uteri by qRT-PCR. N = 3 for each group.
(D and E) Uteri, pregnancy day 5.5 mice of denoted genotypes. Arrows mark the embryo implantation sites. Arrowheads denote ovaries.
(F–I) Morphology of the decidual response in day 2 and day 5 post decidual stimulation. Right horn was stimulated in all groups.
(J–N) PGR levels in uteri of OVX 6-week-old mice treated with 1 mg P4 or vehicle for 6 hr. (J–M) Immunohistochemical analysis of PGR protein. LE, luminal
epithelium; GE, glandular epithelium. (N) Protein levels of both isoforms of the PGR by western blot. Error bars represent SEM. ***p < 0.001, ns, p > 0.05 by
Student’s t test.
See also Figure S1.
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Table 1. Count of Embryo Implantation and Serum P4 Levels
Female
Genotype
No. of Females with
Implantation Sites
Average No. of
Implantation Sites
Average Size of Decidual
Balls (mm)
Serum Progesterone
Levels (ng/mL)
Gata2f/f N = 10 6 7.67 ± 0.42 (6) 1.93 ± 0.06 (6) 32.94 ± 6.44
Gata2d/d N = 6 0 0 N/A 30.03 ± 6.29
Numbers in parenthesis denote the number of female mice used for analyses. N/A, not applicable.results collectively indicate the requirement of Gata2 to sustain
PGR expression for P4 signaling.
Suppression of uterine E2 signaling and E2-driven epithelial
proliferation is a hallmark of P4-induced preparation for
subsequent embryo implantation (Wetendorf and DeMayo,
2014). Compared with Gata2f/f uteri, Gata2d/d day 3.5 pseudo-
pregnancy uteri showed an increased level of phosphorylation
at serine 188 on ESR1 as well as increased expression of the
target Mucin 1, transmembrane (MUC1) (Figure S2A) with no sig-
nificant change in Esr1 mRNA levels (Figure S2B). Thus, the
Gata2d/d mice exhibited higher E2 signaling activities without
elevated ESR1 levels. We also observed altered proliferation of
the uterine epithelia in response to heightened E2 signaling after
loss of Gata2. Normally, epithelial proliferation is high at day 2.5
and diminished at day 3.5 (Figures S2C and S2D). In contrast,
uterine epithelial proliferation at day 3.5 remained as high as
at day 2.5 in the Gata2d/d mice (Figures S2C and S2D). Taken
together, these results demonstrate uninhibited E2 signaling
and reduced P4 signaling as a result of Gata2 deficiency.
The mechanism by which Gata2 regulates PGR expression
was investigated by determining the ability of Gata2 to regulate
the expression of PGR at the level of Pgr gene transcription. Pgr
mRNA levels was reduced in Gata2d/d uteri compared to con-
trols (Figure 3A). Chromatin immunoprecipitation qPCR (ChIP-
qPCR) analysis further shows enriched GATA2 occupancy at a
region that consists of three predicted GATA binding motifs up-
stream and proximal to the Pgr promoter in uteri of OVX Gata2f/f
mice 1 hr post P4 treatment (Figures 3B and 3C). This enrich-
ment was absent in Gata2d/d mice and in the exon 4 negative
control region devoid of GATA binding motifs (Figures 3B and
3C), supporting the finding of GATA2 occupancy at the Pgr lo-
cus. Results from luciferase reporter analysis in cultured epithe-
lial cells showed that the Pgr promoter was stimulated with the
full length Gata2 construct and with the amino zinc finger
deletion (DNT) construct but not with the carboxyl zinc finger
deletion (DCT) construct (Figure 3D). This is consistent with a
previous finding that the carboxyl zinc finger domain is involved
in transcriptional regulation by GATA2 (Tong et al., 2000). The
in vitro GATA2DCT mutant protein results support the in vivo
functional loss of our Gata2 mutant mice in which the carboxyl
zinc finger domain is deleted upon cre-mediated excision. Inter-
estingly, deleting the amino zinc finger domain of GATA2 did not
affect transactivation activity by GATA2 in the Pgr promoter
(Figure 3D), despite a previous report that both zinc fingers
are important for suppressing the PPARg2 promoter (Tong
et al., 2000). Our results demonstrate that GATA2 can enhance
Pgr promoter activity with its carboxyl zinc-finger domain.
Collectively, we find that Pgr is a direct downstream target of
GATA2.Significant Overlap betweenGATA2 and PGRBinding on
Uterine P4 Response Genes
Due to the observed interdependence between PGR andGATA2
expression in uterine P4 signaling, we hypothesized that both
transcription factors are required for the regulation of target
gene expression. This hypothesis was tested by conducting
chromatin immunoprecipitation sequencing (ChIP-seq) analysis
for GATA2 on uterine chromatin isolated from OVX C57BL/6
mice treated with 1 mg P4 s.c. for 1 hr and immunoprecipitated
for GATA2 (Rubel et al., 2012b). Whole uterine analysis resulted
in over 22 3 106 tags mapping to unique locations in the mouse
genome. A model-based analysis peak-finding algorithm
(MACS) (Zhang et al., 2008) was utilized to normalize immuno-
precipitated chromatin against uterine input generating a false
discovery rate of essentially zero. This high-confidence cutoff
produced 46,183 GATA2 binding intervals. Analysis for DNAmo-
tifs in the GATA2 cistrome revealed the expected GATA binding
motifs as well as PGR binding motifs within the GATA2-occu-
pying intervals (Figures 4A and 4B). To investigate whether this
PGR binding motif enrichment in GATA2 occupying sites is
uterus-specific, we compared GATA2 occupancy patterns and
motif enrichment between two distinct tissue types, the uterus
and HPC7 hematopoietic precursor cells (Wilson et al., 2010).
Among 46,183 uterine and 9,243 HPC7 cell GATA2 occupying
sites, GATA2 exhibited distinct cistrome profiles with 96.7%
and 83.3% sites unique to uterus and HPC7 cells, respectively
(Figure S3A). This finding is similar with a previous study in which
GATA2 cistromes are significantly different between precursor
cells and differentiated mast cells (Calero-Nieto et al., 2014).
Motif analyses further revealed that the uterine GATA2 cistrome
contained binding motifs enriched for nuclear receptors, such as
PGR, glucocorticoid receptor (GR), and androgen receptor (AR)
among others (Table S4), while such enrichment was not present
in the HPC7 GATA2 cistrome (Table S4). Similarly, motifs of Sex
Determining Region Y Box (SOX) factors are also enriched in the
uterine, but not the HPC7 cell GATA2 cistrome (Table S4). It is
worthy to note that SOX17 is also expressed in the uterine
epithelial cells (Rubel et al., 2012b) where GATA2 is expressed
and functions in the process of embryo implantation (Hirate
et al., 2016). These findings revealed a uterine-specific GATA2
occupancy pattern that is associated with the presence of bind-
ing motifs of transcription factors, such as PGR and SOX17, that
have been known to regulate uterine function.
Because PGR binding motifs are enriched in the GATA2 cis-
trome, we aligned the GATA2 location data with previous PGR
ChIP-seq performed for mouse uterus (Rubel et al., 2012b).
These PGR ChIP-seq data were also conducted on the uteri of
OVX mice treated with 1 mg P4 for 1 hr. Through overlaying
the GATA2- and PGR-occupying genes (defined by having atCell Reports 17, 1414–1425, October 25, 2016 1417
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Figure 2. Impaired P4 Signaling in Gata2-
Deficient Uterus
OVX mice were treated with vehicle (oil) or 1 mg P4
for 6 hr.
(A–C) mRNA levels of PGR target genes assayed by
qRT-PCR. n = 3 for each group.
(D and E) Gene expression profiling by microarray
assays on denoted treatments and genotypes.
(D) Venn diagram of numbers of P4-responsive
genes in denoted genotypes. (E) Magnitude of P4-
responsiveness on expression of the common
P4-responsive genes between denoted genotypes
in (D).
(F and G) Genome-wide expression profiles of
Gata2-dependent genes in the presence of P4. (F)
Heatmap of hierarchically clustered profiles. Low
expression values are blue and high expression
values are yellow. n = 3 for each group. (G) Pre-
dicted regulators of Gata2-dependent genes by the
Ingenuity Pathway Analysis. Error bars represent
SEM. *p < 0.05, **p < 0.01, ***p < 0.001 by Student’s
t test.
See also Figure S2 and Tables S1, S2, S3, and S7.least one ChIP interval within 25 kb of annotated gene bound-
aries) with P4-responsive genes derived from the microarray
results, we foundGATA2 occupancy in 1,478 (79%) and PGR oc-
cupancy in 1,013 (54%) P4 response genes (Figure 4C). Strik-
ingly, GATA2 and PGR occupying sites are present together on
935 (50%) genes regulated by P4 (Figure 4C). We validated the
GATA2 occupancy on 13 genes (15 locations total) that are pre-
viously identified to contain PGR binding sites (Rubel et al.,
2012b). All validated sites were within known P4 responsive
genes, and several of these GATA2 occupying locations directly
overlapped with those of PGR occupying sites (Figure S3B). In
summary, these findings suggest a major regulatory mechanism
of P4 response genes jointly by GATA2 and PGR.
Joint Regulation of Transcription by GATA2 and PGR
The functionality of the overlap of PGRandGATA2 intervals in the
regulation of gene expression was tested by conducting lucif-
erase reporter analysis on putative enhancers containing over-
lapping PGR and GATA2 binding sites from chromatin locations
in two P4 target genes, Sox17 and Ihh (Figure 4D) (Lee et al.,
2006; Rubel et al., 2012b). The GATA2-PGR intervals were sub-
cloned into a luciferase vector containing a minimal promoter
and thenco-transfectedwith combinations of vectors expressing
PGR-A, PGR-B, and GATA2 to evaluate the possible regulatory
preferences of these factors on these putative enhancers of P41418 Cell Reports 17, 1414–1425, October 25, 2016t-
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onarget genes. The results showed that lucif-
erase activities under the control of these
putative enhancers increased in response
to progestin (R5020) treatment in a Pgr iso-
form-specific manner (Figures 4E and 4F).
No induction of these reporter genes was
observed with cotransfection of the Gata2
alone. However, when Gata2 was cotrans-
fectedwith thePgr isoforms, these reporter
plasmids showed a significant inductionluciferase activity in the presence of R5020 treatment (Figures
and 4F). These results are consistent with our hypothesis th
PGR and GATA2 can coordinate the expression of these targ
genes and with the observation of GATA2 regulating PG
response genes in vivo (Figures 2C and S3C).
The ChIP-seq result also identified multiple GATA2 occupyi
sites in the Pgr locus (Figure S4A), including the proximal pr
moter region that contains predicted GATA binding motif a
is corresponding to the Pgr promoter fragment in the lucifera
construct (Figure S4B). Interestingly, the Pgr proximal promot
region exhibited a high GATA2 and low PGR occupying profi
(Figure S4B). This occupancy pattern is consistent with the luc
erase promoter assay result where GATA2 alone can enhan
the Pgr promoter activity (Figure 3D), which is in contrast w
the GATA2/PGR co-occupying enhancers where GATA2 c
activated transcription with PGR (Figures 4D–4F). Our resu
demonstrate that GATA2 employs two mechanisms to regula
P4 signaling through directly controlling Pgr gene transcripti
as well as co-regulating PGR downstream gene expressi
with PGR.
Progesterone-Independent Function of Gata2 in
Suppressing p63
The role of Gata2 in hormone-independent gene regulation
uterine function was investigated by comparing the expressi
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Figure 3. Binding and Regulation of Pgr by
GATA2
(A) Pgr mRNA levels by qRT-PCR in uteri of OVX
mice acutely treated with vehicle for 6 hr.
(B) Gata2 binding sites in the Pgr promoter. Red
denotes GATA2 binding motifs. PCR primers used
for ChIP-qPCR analysis are listed here.
(C) ChIP-qPCR analysis of GATA2 occupancy on
Pgr proximal promoter in uteri 1 hr after P4 treat-
ment in OVX mice.
(D) Luciferase reporter analysis of Pgr promoter
activities in response to various GATA2 expression
vectors. GATA2, full-length GATA2; DNT, GATA2
N-terminal zinc-finger deleted mutant; DCT, GATA2
C-terminal zinc-finger-deleted mutant. Error bars
represent SEM. *p < 0.05, **p < 0.01, ***p < 0.001 by
Student’s t test.profiles of Gata2d/d and Gata2f/f treated only with vehicle. Micro-
array analysis revealed 426 genes upregulated and 535 downre-
gulated (Table S5). IPA revealed enrichment in cancer and
proliferation of keratinocytes/epidermal cells (Figure 5A), as evi-
denced by the Gata2d/d uteri exhibiting ectopic expression of
TRP63 in a layer of cells, morphologically similar to basal cells,
underneath the columnar luminal epithelia (Figure 5D). Because
TRP63 is a molecular switch for squamous metaplasia (Koster
et al., 2004) associated with in utero exposure to the synthetic
E2 diethylstilbestrol (DES) (Franco et al., 2011; Goldberg and Fal-
cone, 1999; Sassoon, 1999), we hypothesized that Gata2 defi-
ciency may increase susceptibility in developing squamous
metaplasia in response to E2 signaling. Long-term treatment of
OVX mice with E2 resulted in development of focal regions of
TRP63-positive cells into squamous cell metaplasia as early
as 2 weeks post treatment (Figure 5F), with Trp63 expression
over time (Figures 5G and S5). An increase in expression ofre
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ToCell Repkeratin genes, including Krt5 and Krt15,
in Gata2f/f mice (Figures 5H and 5I) was
also observed. These changes were not
observed in the control mice (Figure 5E).
In summary, our results revealed a Gata2-
dependent and P4-independent mecha-
nism in suppression of Trp63 expression
and a role in squamous metaplasia. This
demonstrates that Gata2 is critical for
the uterine epithelium to maintain its differ-
entiated state.
A Conserved GATA2-Dependent
Regulatory Network in Human
Endometrium
The clinical relevance of our findings in
mouse models was evaluated by deter-
mining whether there is an association
between the GATA2 and P4 signaling in
human uterine expression databases. We
first identified human orthologs of Gata2-
regulated mouse genes in the presence
of P4 (Figure 2F). Based on these GATA2porter genes originally derived from the mouse (Figure 6A,
p panel), we then determined the humanGATA2 gene activities
individual endometrial tissue of 115 human samples (NCBI:
E58144) (Koot et al., 2016). A positive correlation between
TA2 levels and activities in human samples, just as in mouse,
s observed (Figures 6A and S6A). Moreover, in the same
hort of human samples, we found GATA2 activities are
sitively correlated with levels of PGR and of members of
R signaling components PTCH1, AREG, FKBP4, PTGS2,
d SOX17 (Figures 6A and S6A). Taken together, these results
ggest a conserved GATA2 regulatory network in human and
ouse endometrium.
Results from our studies and others revealed a regulatory
twork for female fertility (Figure 6B) that consists of GATA2,
R, and SOX17 transcription factors (Guimar~aes-Young
al., 2016; Hirate et al., 2016; Rubel et al., 2012a, 2012b).
investigate this network in human endometrial samples, weorts 17, 1414–1425, October 25, 2016 1419
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Figure 4. Binding of GATA2 and PGR at Loci of Uterine P4-Responsive Genes
(A and B) Enriched GATA2 and PGR binding motifs at GATA2 binding intervals that were identified by ChIP-seq in OVX mouse uteri 6 hr after P4 treatment.
(C) Venn diagrams of P4-regulated genes that contain binding sites for PGR or GATA2 within ±25 kb of gene boundaries.
(D) Occupancy of PGR and GATA2 in putative enhancers for Sox17 and Ihh genes in P4-treated uteri. Blue indicates PGR while red indicates GATA2 occupancy.
Brackets mark the regions used for luciferase reporter analysis.
(legend continued on next page)
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performed path analyses on the NCBI: GSE58144 dataset using
a structural equation modeling (Xiong et al., 2004). First, we
examined a model in which GATA2 and PGR are mutually regu-
lated and both transcription factors jointly modulate SOX17,
based on mRNA levels of each gene (Figure 6C). This model
significantly fits the data fromNCBI: GSE58144with all proposed
paths (Figure 6C). The fit indices of the tested model all provided
evidence of a close fit in which root-mean-square error of
approximation (RMSEA) is <0.001, standardized root-mean-
square residual (SRMR) is <0.001, comparative fit index (CFI)
equals to 1.0, and Tucker Lewis fit index (TLI) equals to 1.0 (Fig-
ure S5B). Based on results of these indices, this model is consid-
ered not rejected by the human data. Additionally, both GATA2
and PGR have significant direct effects on SOX17 (p < 0.05).
Overall, higher GATA2 and PGR levels were associated with
higher SOX17 levels. Furthermore, using the GATA2 signature
(Figure 6A) and the PGR signature (derived from NCBI:
GSE39920, Table S6) as molecular activities to replace GATA2
and PGR levels in the model also yielded statistically significant
results (Figures 6D andS6B). Collectively, these findings suggest
the presence of a GATA2-PGR-SOX17 regulatory network in the
NCBI: GSE58144 dataset of human endometrial tissues.
Next, we tested themodel of joint regulation of the P4 signaling
by GATA2 and PGR. Activities of human P4 signaling in NCBI:
GSE58144 were generated based on a mouse P4 signature (Fig-
ure 2D). Model fitting of data fromNCBI: GSE58144 via structural
equationmodeling shows statistical significance on all proposed
paths (p < 0.05) (Figure 6E) while the model is considered not
rejected by the human NCBI: GSE58144 data based on RMSEA,
SRMR, CFI, and TLI indices (Figure S6B). In summary, these re-
sults suggest that, in humans,GATA2 andPGR together regulate
P4 signaling and form a network with SOX17 to direct a tran-
scription program for female fertility.
DISCUSSION
Our study demonstrated that GATA2 modulates PGR signaling
via regulation of Pgr transcription and through GATA2-PGR
interaction in transcriptional regulation of P4 response genes.
These results are consistent with a previous study that shows
that binding of GATA2 with PGR is essential for the expression
of a known P4 target gene Fkbp5 in mouse mammary cancer
cells (Magklara and Smith, 2009). Thus, in conjunction with our
previous findings on regulation of Gata2 by PGR (Rubel et al.,
2012a), we show the reciprocal regulation of Gata2 and Pgr
that allows both genes to be present to regulate the transcription
of key genes involved in the preparation of the mouse uterus for
embryo implantation. This finds further support from the model
fitting analysis in human endometrial tissues, suggesting a con-
servation of the molecular mechanism across species. Several
studies have provided evidences for the cooperative nature of
GATA2 with the androgen receptor (AR) in androgen-induced(E and F) Luciferase reporter analyses of cotransfection analysis of denoted cis
PGR-B, or GATA2 expression vectors treated with vehicle or 108 M R5020 fo
*p < 0.05; ***p < 0.001 by Student’s t test.
See also Figures S3 and S4; Table S4.gene response, while the expression of AR itself is also regulated
by GATA2 (Perez-Stable et al., 2000; Wu et al., 2014). Given that
androgen response elements (AREs) contain sequence homol-
ogy with that of P4 response elements (PREs), our study high-
lights the amazing resemblance between GATA2-PGR and
GATA2-AR in regulation of gene expression.
Recently, GATA2 has been reported to be downregulated in
endometriosis samples in humans in Dyson et al. (2014). They re-
ported that PGR expression failed to respond to manipulation of
GATA2 levels, which is different from our observation from the
in vivo mouse model. This discrepancy likely resulted from the
cell type difference; we primarily observed the Gata2-Pgr inter-
action in epithelial cells while Dyson et al. (2014) conducted ex-
periments in stromal cells. Owing to the fact that OVXmice are in
the hormone-deprived state during which basal expression of
PGR is restricted to the luminal epithelium and glands (Figures
1I and 1K), the epithelial derived P4 signaling is likely the primary
source of acute P4 responses observed in our studies.
Interestingly, as a P4-independent phenotype, ablating Gata2
in the uterus resulted in endometrial epithelial morphology
alteration from simple columnar epithelium into stratified squa-
mous epithelium, in association with increased TRP63 expres-
sion. TRP63, particularly the delta N isoform, has been sug-
gested as a driver in the developmental switch from a simple
epithelium to a squamous epidermal fate (Romano and Sinha,
2011). The stratified endometrial epithelial phenotype shown
here is similar to exposure to DES in fetal or neonatal mice (Iguchi
and Takasugi, 1987; Plapinger, 1981). A similar disruption of hu-
man uterine differentiation was observed when DESwasmistak-
enly prescribed to pregnant women during 1947–1971 under the
assumption of preserving the pregnancy. This exposure associ-
ated with increasing reproductive tract anomalies including
vaginal adenosis and endometrial cancer in their daughters (Ha-
ney et al., 1979; Herbst et al., 1971). Due to the dependence of
E2 during this process, we further demonstrated that loss of
Gata2 resulted in a squamous cell metaplasia phenotype in the
glandular and luminal epithelium that was marked by the pres-
ence of TRP63 after chronic E2 treatment. Uterine disruption of
a number of transcription factors, including Wnt signaling
Wnt7a, Wnt4, Wnt5a, and Ctnnb1 (Franco et al., 2011; Jeong
et al., 2009; Mericskay et al., 2004; Miller and Sassoon, 1998),
as well as Hox family members Hoxa10, Hoxa11, and Hoxa13
(Benson et al., 1996; Zhao and Potter, 2001), also resulted in
uterine epithelial morphological alteration. Future experiments
will need to define the relationship of GATA2 with Wnt signaling
in this process. Our results demonstrate that Gata2 is critical for
the maintenance of normal uterine epithelia differentiation.
The presence of P4- and GATA2-independent genes in the
GATA2 and P4 targets, respectively, suggests involvement of
additional mechanisms in controlling these two groups of genes.
To explore potential signals that regulate expression of genes
responded uniquely to P4 but not GATA2, we performed motif-acting elements in HEC-1A cells. Cotransfection with empty vector, PGR-A,
r 24 hr. Experiments were performed in triplicate. Error bars represent SEM.
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Diseases or Functions Annotation p-Value Activation z-score # Molecules
abdominal cancer 7.32E-19 1.527 683
urogenital cancer 7.20E-11 1.932 354
proliferation of epithelial cells 1.05E-08 1.483 56
growth of tumor 7.48E-08 1.410 78
proliferation of keratinocytes 1.58E-05 2.380 20
proliferation of epidermal cells 2.27E-05 2.480 21
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Figure 5. P4-Independent Functions of Gata2
(A) Enrichment of functional annotation in differentially
expressed genes between Gata2f/f and Gata2d/d uteri of
OVX, vehicle-treated mice by IPA analysis.
(B) mRNA levels of TRP63 in uterus of OVX mice.
(C and D) Immunostaining of TRP63 in uteri of OVX mice
(control horn of decidualization treatment). Scale bar,
100 uM.
(E and F) Immunostaining of TRP63 in uteri of OVX mice
treated with E2 for 2 weeks.
(G) qRT-PCR of uterine tissues of OVX mice treated
with E2. n = 6 (Gata2f/f, vehicle, 2 weeks), 6 (Gata2d/d,
vehicle, 2 weeks), 6 (Gata2f/f, E2, 2 weeks), 6 (Gata2d/d,
E2, 2 weeks), 6 (Gata2f/f, vehicle, 4 weeks), 6
(Gata2d/d, vehicle, 4 weeks), 4 (Gata2f/f, E2, 4 weeks), 6
(Gata2d/d, E2, 4 weeks), 6 (Gata2f/f, vehicle, 2 months),
4 (Gata2d/d, vehicle, 2 months), 6 (Gata2f/f, E2,
2 months), 5 (Gata2d/d, E2, 2 months).
(H and I) qRT-PCR of uterine tissues of OVX mice
treated with E2 for 2 months. Error bars represent SEM.
*p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test.
See also Figure S5 and Table S5.analysis on genes differentially expressed upon P4 stimulation in
the Gata2 knockout background (Figure 2D, red circle). Search-
ing for knownmotifs in promoter regions of these genes revealed
an enrichment of AP2 and RBPJ1 binding motifs (Table S7A).
Given that the AP2 binding motif is also enriched in the PGR oc-
cupancy sites in T47D breast cancer cell lines (Yin et al., 2012),
perhaps a conserved regulatory mechanism that consists of
PGR and AP2 is present for a subset of PGR target genes. This
result also suggests that PGR might work with multiple pioneer
factors, such as GATA2 and AP2, to regulate various subsets
of PGR downstream targets. On the other hand, we found a
different profile of enriched motifs in promoter regions of genes
downstream to GATA2 responsive genes without the need of
P4 stimulation (Tables S5 and S7B). In this group, the binding1422 Cell Reports 17, 1414–1425, October 25, 2016p-
all
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ionmotif for Forkhead box (FOX) proteins is en-
riched in the GATA2 occupying sites, which
bears a resemblance of co-occupancy of
GATA2 and FOXA1 in genomic loci of AR
target genes in prostate cancer (Wu et al.,
2014). Furthermore, the enrichment of SOX
(SexDetermining Region YBox) factor binding
motifs also implicates a potential interaction
between GATA2 and other uterine transcrip-
tion regulators such as SOX17 (Garcia et al.,
2007; Guimar~aes-Young et al., 2016; Hirate
et al., 2016). These results indicate future
investigations on potential mechanisms by
which GATA2 and PGR work independently
with other transcription regulators to direct
gene expression in the uterus.
In summary, this study contributes to amore
comprehensive understanding of P4 regula-
tion through the identification of a role for the
transcription factor GATA2 in uterine function.
The morphological alteration of endometrial
epithelium in response to Gata2 deficiencysuggests thatGata2may play a role in postnatal uterine develo
ment. Given that GATA2 activities can be modulated by sm
molecules (He et al., 2014), fully understanding the interactio
of Gata2 with the network of genes involved in the regulation
uterine function will have implications for the future treatment
female reproductive health and associated disorders.
EXPERIMENTAL PROCEDURES
Animals and Hormone Treatments
Mice were maintained in the designated animal care facility at Baylor Colle
ofMedicine (BCM) according to the Institutional Animal Care andUse Comm
tee (IACUC) guidelines for the care and use of laboratory animals. All anim
experiments were performed in accordance with an IACUC approved pro
col. Detailed description of fertility assay, superovulation, embryo implantat
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Figure 6. A GATA2-Dependent Regulatory
Network in Human Endometrium
(A) Top: expression array data of 115 human endo-
metrial tissue samples from NCBI: GSE58144, for
genes in a transcriptional signature of GATA2, with
samples ordered based on manifestation of the
signature. Bottom: heatmap shows levels of genes of
interest in individual samples corresponding to the
order in the top panel.
(B) Network of transcription factors for regulation of
female fertility.
(C and D) Path analysis of the genetic network by
mRNA expression levels and gene signature in NCBI:
GSE58144 through structural equation modeling.
GATA2 and PGR signatures were derived from (A) and
NCBI: GSE39920, respectively.
(E) Model fitting for regulation of P4 signaling by
GATA2 and PGR. The P4 signature is based on a gene
list described in the green box of Figure 2D. Brackets
denote mRNA levels. p values are derived by path
analysis based on linear statistic models.
See also Figure S6 and Table S6.assessment, and artificial decidualization are listed in the Supplemental
Information.
Microarray Analysis
Detailed sample preparation can be found in the Supplemental Information. All
experiments were performed in triplicate with independent pools of RNA.
The Partek Genomics Suite 6.6 software (Partek) was utilized to process raw
data fromCEL files. The Robust Multichip Analysis (RMA) algorithmwith quan-
tile for normalization and log2 transformation was applied to generate signal
values of all samples. The one-way ANOVA model was used to compare
expression profiles from different groups. Differentially expressed genes
were defined using the filters of ANOVA unadjusted p value <0.01 and absolute
fold change >1.3.
ChIP-Seq and Data Analysis
GATA2 and input ChIPs were performed by ActiveMotif onmouse uteri treated
with P4 and with GATA2 antibody (sc-9008, Santa Cruz) as described in the
Supplemental Information. The model-based analysis of ChIP-sequencing
(MACS) peak finding algorithm was used to normalize ChIP against input
control (Zhang et al., 2008). Specifically, a p value of 1010 was used with
this software to identify ChIP peaks in this work by comparing them to input.
Genes associated with intervals were assessed using two increasingly less
stringent requirements; if it was within 10 kb and 25 kb upstream or down-
stream of a gene, it was counted. Analysis of enriched motifs and CEAS
were performed using the Cistrome Analysis Pipeline software (http://
cistrome.org/ap/rootunder default settings (Liu et al., 2011) or using theref
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moCell ReHOMER (Heinz et al., 2010). For gene functional clas-
sifications, the web application tool Database for
Annotation, Visualization, and Integrated Discovery
(DAVID, https://david.ncifcrf.gov/) running default set-
tings was used (Huang et al., 2009).
Signature Analysis
The publicly available human recurrent implantation
failure (RIF) array dataset NCBI: GSE58144 was
scored for manifestation of the mouse model-derived
GATA2 signature, using published methods (Qin et al.,
2013). In brief, a gene signature score (t score) was
defined for each human sample as the two-sided
t-statistic comparison of the high GATA2-signature
with the low GATA2-signature genes’ expression
profile. Where multiple probes in NCBI: GSE58144erred to the same gene, the probe with the highest variation was chosen
represent the gene. For each gene, the profiles were centered to the median
ross samples. Expression pattern was displayed as heatmap using Partek
nomics Suite 6.6 software.
th Analysis on Human Data
test the relationships among variables proposed in the research models,
uctural equationmodelingwasconducted to indicate the strength of influence
ong variables by getting an overall fit of model with the data. Goodness-of-fit
ts were performed to determine whether the research models should be
cepted or rejected. Models were analyzed using Mplus software version
1 (Muthe´n&Muthe´n).Basedon the researchmodels, thesignificanceofdirect
d indirect relationships among variables was examined. All observed data
re includedwhen fitting themodels. Therewas nomissingdata in the dataset.
The fit of the models was assessed using several methods including the
t-mean-square error of approximation (RMSEA), along with a 90% confi-
nce interval, the standard root-mean-square residual (SRMR), the Compar-
ve Fit Index (CFI), and the Tucker-Lewis Fit Index (TLI) to determine the
tent to which the relationships existing in the data are consistent with those
posed by the models (Hu and Bentler, 1998, 1999; MacCallum et al., 1996).
interpret the RMSEA, the general rule of thumb is that values <0.05 indicate
se fit, values between 0.05 and 0.10 indicate marginal fit, and values >0.10
icate poor fit (MacCallum et al., 1996). For both CFI and TLI, a value of 1
icates perfect fit and the values >0.9 indicate adequate fit (Hu and Bentler,
98, 1999). Values <0.08 for SRMR indicate a very good fit between the
del and the data.ports 17, 1414–1425, October 25, 2016 1423
Histology
Alkaline phosphatase activity assay was performed on frozen sections. Immu-
nohistochemistry analysis was carried out in paraformaldehyde-fixed, paraffin
sections with PGR (A0098, Dako) and TP63 (sc-8431, Santa Cruz) antibodies.
Detail information is in the Supplemental Information.
Biochemical, Molecular, and Cell Culture Assays
qRT-PCR was performed with TaqMan probes listed in Table S1. Statistical
analyses were performed using t test or one-way ANOVA followed by Tukey’s
post hoc multiple range test with the Instat package from GraphPad
(GraphPad Software). Western blot analysis was carried out with PGR
antibody (sc-7208, Santa Cruz). Human endometrial epithelial cells were uti-
lized for transient transfection assays. Detailed descriptions are listed in the
Supplemental Information.
ACCESSION NUMBERS
The accession number for themicroarray data and the ChIP-seq data reported
in this paper is NCBI: GSE40661.
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six figures, and seven tables and can be found with this article online at
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